Evidence map›Paper›PMID 41234529›Full record

ArticleBrain communications2025

White matter hyperintensities drive propagating grey matter atrophy in cerebral small vessel disease.

Ronghua Mu, Peng Yang, Xiaoyan Qin, Wei Zheng, Jian Lv, Bingqin Huang, Xin Li, Yuling Feng, Danyi Huang, Peijia Li and 3 more

Abstract read
In one paragraph

Article in Brain communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ronghua MuDepartment of Radiology, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin 541004, China.
Peng YangDepartment of Radiology, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin 541004, China.
Xiaoyan QinDepartment of Radiology, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin 541004, China.
Wei ZhengDepartment of Radiology, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin 541004, China.
Jian LvDepartment of Radiology, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin 541004, China.
Bingqin HuangDepartment of Radiology, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin 541004, China.
Xin LiDepartment of Radiology, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin 541004, China.
Yuling FengDepartment of Radiology, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin 541004, China.
Danyi HuangDepartment of Radiology, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin 541004, China.
Peijia LiDepartment of Radiology, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin 541004, China.
Siyu DaiDepartment of Radiology, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, Guilin 541004, China.
Luqi ChengSchool of Life and Environmental Sciences, Guilin University of Electronic Technology, Guilin 541004, China.
Xiqi ZhuDepartment of Radiology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise 533000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

WMH, a neuroimaging marker of cerebral small vessel disease, is closely associated with cognitive decline and structural brain changes. However, the precise mechanisms through which WMH-associated GMV changes ultimately translate to cognitive decline remain unclear, particularly regarding propagation patterns and causal interactions within affected neural circuits. To investigate the progressive structural changes in WMH patients based on disease severity, we recruited 185 patients with cerebral small vessel disease and 40 healthy controls, who underwent magnetic resonance imaging scans. First, voxel-based morphometry analysis was performed to compare GMV differences between WMH patients and healthy controls, followed by subgroup analyses across different disease stages to identify key regions with significant morphological changes. Subsequently, causal structural covariance network analysis, modularity analysis and functional decoding were employed to map the causal relationships of GMV changes, the hierarchical topography and functional characteristics of the structural network throughout the WMH progression. Finally, mediation analysis was conducted to explore the relationships between WMH volume, GMV, and cognition, providing insights into the underlying causal pathways. The results revealed that GMV reductions originated in the right insula and progressively extended to cortical and subcortical regions with increasing disease severity. Causal structural covariance network analysis identified the right insula as a central hub, exerting causal effects on GMV reductions in regions associated with executive function and attention. Modularity analysis and functional decoding further highlighted key pathways linking the right insula to cortico-subcortical networks involved in cognitive regulation and motor coordination. Additionally, compensatory GMV increases were observed in specific regions, suggesting neuroplastic responses to WMH-related damage. Mediation analysis demonstrated that GMV reductions significantly mediated the relationship between WMH volume and cognitive impairments, particularly in executive function and processing speed. Overall, the right insula acts as a critical hub driving hierarchical GMV atrophy and network disruption in WMH. Its early involvement and causal influence highlight its importance as a potential target for interventions to mitigate cognitive decline.

Indexed as

causal structural covariance networkgrey matter volumeinsulamagnetic resonance imagingwhite matter hyperintensities

Identifiers

PMID41234529
PMCPMC12609173

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.